Cameroon vs Eswatini: Treatment coverage for schistosomiasis
Cameroon
56.3%
in 2024
Eswatini
53.5%
in 2024
Cameroon rank
15th
Eswatini rank
18th
Treatment coverage for schistosomiasis over time
- Cameroon
- Eswatini
How they compare
Cameroon currently reports 56.3% against 53.5% in Eswatini, a difference of 2.8%.
That makes Cameroon's figure about 1.1 times Eswatini's.
The two have swapped places 1 time across 5 shared years of data; in 2007 it was Eswatini ahead.
Cameroon ranks 15th and Eswatini ranks 18th of 45 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Eswatini in 2.
Head to head by decade
| Decade | Cameroon | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 9.8% | 5.3% | Eswatini |
| 2010s | 31.6% | 59.2% | 27.6% | Eswatini |
| 2020s | 56.3% | 53.5% | 2.9% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cameroon or Eswatini?
- Cameroon, at 56.3% against 53.5% in Eswatini as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Cameroon and Eswatini?
- 2.8%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Eswatini?
- 5 years are reported by both, from 2007 to 2024.
- How do Cameroon and Eswatini rank globally for treatment coverage for schistosomiasis?
- Cameroon ranks 15th and Eswatini ranks 18th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.